Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study-Reference-Cited by-同舟云学术

Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study

Published:2014-07-30 Issue:4 Volume:74 Page:699-709
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Kobayashi Shogo,Nagano Hiroaki,Sakai Daisuke,Eguchi Hidetoshi,Hatano Etsuro,Kanai Masashi,Seo Satoru,Taura Kojiro,Fujiwara Yutaka,Ajiki Tetsuo,Takemura Shigekazu,Kubo Shoji,Yanagimoto Hiroaki,Toyokawa Hideyoshi,Tsuji Akihito,Terajima Hiroaki,Morita Satoshi,Ioka Tatsuya

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-014-2543-4.pdf

Reference30 articles.

1. Yamanaka K, Hatano E, Kanai M, Tanaka S, Yamamoto K, Narita M, Nagata H, Ishii T, Machimoto T, Taura K, Uemoto S (2014) A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer. Int J Clin Oncol 19(3):485–489

2. Kobayashi S, Nagano H, Marubashi S, Wada H, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M (2011) Treatment of borderline cases for curative resection of biliary tract cancer. J Surg Oncol 104(5):499–503

3. Miyakawa S, Ishihara S, Horiguchi A, Takada T, Miyazaki M, Nagakawa T (2009) Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg 16:1–7

4. Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y (2007) Surgical resection of hilar cholangiocarcinoma. Analysis of survival and postoperative complications. World J Surg 31(6):1256–1263

5. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95(8):1685–1695

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202;European Journal of Surgical Oncology;2024-02

2. Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations;Hepatology;2024-01-24

3. Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study);Oncology;2023-12-04

4. Current progress in perioperative chemotherapy for biliary tract cancer;Annals of Gastroenterological Surgery;2023-05-16

5. Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma;Annals of Surgical Oncology;2022-01-07